Home | Medical-Newswire.Com:
(Medical-NewsWire.com, November 10, 2017 ) The Europe Stem Cell Assay Market was worth USD 140.7 Million in 2016 and is estimated to be growing at a CAGR of 19.3%, to reach USD 340.11 Million by 2021. Stem cells are a type of cells in human body and possess the ability to develop into any other cell in the body. After cell division, they can again produce stem cells. Due to this regenerative ability of the stem cells, they are capable of repairing damaged tissues or organs.
There are two major sources of stem cells in humans. One is from the blastocyst stage of human embryo and the other is adult stem cells and are available from bone marrow, brain, spinal cord etc. Stem cells are applied in medicine to develop therapies for diseases such as Alzheimers. Stem cell assays analyze the functional capabilities of derived stem cells and assess the quality of the cells.
View full report @ http://www.marketdataforecast.com/market-reports/europe-stem-cell-assay-market-3675/
Rise in aging population and chronic diseases, increase in investments for research on stem cells and the development of stem cell therapy are the major factors driving the stem cell assays market. Increases restrictions on the use of animals to test the drugs, demand for stem cell assays increased. However, huge costs associated with the research on stem cells and controversies arising because the source of stem cells being the human embryo is restraining the market.
The Europe stem cell assay market is segmented based on assay type, technology, kits, product, application, end user and region. Based on the assay type, the market is categorized into Cell Viability & Toxicity Assays, Purification Assays, Differentiation assays, function assays, Identification assays, proliferation assays and cell apoptosis assays. The cell viability and toxicity assay is projected to hold the largest market share due to increase in focus on drug testing using stem cells. Based on kits, the market is categorized into Adult stem cell kits and human embryonic stem cell kits. Adult stem cells kits are again segmented into Induced Pluripotent Stem Cell Kits, Mesenchymal Stem Cell Kits, Hematopoietic Stem Cell Kits, Umbilical Cord Stem Cells and Neuronal Stem Cells Kits. Due to the high effectiveness in the analysis of stem cells, adult stem cell kits segment is rapidly growing. Based on product, the market is categorized into Instruments and Detection kits. Instruments are further categorized into Flow cytometer, Cell imaging systems, Micro electrode arrays and automated cell counter. Detection kits include immune histochemistry kits. Flow cytometer is the fastest growing segment due to the rise in demand for tissue analysis and application of cytometers in cancer detection. Based on application, the market is categorized into Regenerative Medicine & Therapy Development, Drug Discovery and Development and clinical research. Regenerative medicine segment is again categorized into Dermatology, Cardiovascular, Orthopedic & Musculoskeletal Spine, Oncology, Central Nervous System and diabetes. Due to the increase in prevalence of chronic diseases, the demand for regenerative medicine has increased attributing to its largest market share. Based on the end users, the market is categorized into research institutes and industry research.
Request sample @ http://www.marketdataforecast.com/market-reports/europe-stem-cell-assay-market-3675/request-sample
Based on region, the Europe stem cell assays market is segmented into UK, Germany, Spain, France and Italy. Germany leads the market in this region due to the increasing adoption of stem cell based research in this country.
Major companies in the stem cell assay market are Merck KGaA, Bio-Techne Corporation, Promega Corporation, Thermo Fisher Scientific Inc., STEMCELL Technologies Inc., Hemogenix, GE Healthcare, Bio-Rad Laboratories, Inc., Cellular Dynamics International Inc., and Cell Biolabs Inc.
Cell Viability & Toxicity Assays
Cell Identification Assays
Cell Differentiation Assays
Cell Proliferation Assays
Cell Apoptosis Assays
Cell Function Assays
Y-o-Y Growth Analysis, By Assay Type
Market Attractiveness Analysis, By Assay Type
Market Share Analysis, By Assay Type
Micro Fabricated Assisted Technology
Microfluidics Based Cell Trap Technologies
Technology in Development
Y-o-Y Growth Analysis, By Technology
Market Attractiveness Analysis, By Technology
Market Share Analysis, By Technology
Adult Stem Cell Kits
Induced Pluripotent Stem Cell Kits
Mesenchymal Stem Cell Kits
Neuronal Stem Cells Kits
Umbilical Cord Stem Cells
Hematopoietic Stem Cell Kits
Human Embryonic Stem Cells Kits
Y-o-Y Growth Analysis, By Kits
Market Attractiveness Analysis, By Kits
Market Share Analysis, By Kits
Micro Electrode Arrays
Cell Imaging Systems
Automated Cell Counter
Immuno Histochemistry Kits
Y-o-Y Growth Analysis, By Product
Market Attractiveness Analysis, By Product
Market Share Analysis, By Product
Regenerative Medicine & Therapy Development
Orthopedic & Musculoskeletal Spine
Central Nervous System
Drug Discovery and Development
Inquire before buying @ http://www.marketdataforecast.com/market-reports/europe-stem-cell-assay-market-3675/inquire
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast